{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-059126","form_type":"8-K","ticker":"BNBX","cik":"0000744452","company_name":"BNB PLUS CORP.","filed_at":"2023-05-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.140084+00:00","generated_at":"2026-06-15T05:15:11.501016+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Applied DNA Q2 FY2023 revenue falls 28% to $4.4M; identifies mRNA acquisition target","bullets":["Total revenues $4.4M, down from $6.1M YoY; COVID-19 testing revenue declined $1.5M.","Operating loss $2.7M vs $2.2M prior year; Adjusted EBITDA -$2.1M vs -$1.6M.","Cash $12.3M as of March 31, 2023, down from $15.2M in December 2022.","Identified mRNA value chain acquisition target; expects closing by June 30, 2023.","Submitted PGx assay validation to NYSDOH; approval anticipated in coming months."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-059126","json":"https://secwatch.observer/filing/0001104659-23-059126.json","markdown":"https://secwatch.observer/filing/0001104659-23-059126.md","text":"https://secwatch.observer/filing/0001104659-23-059126.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/744452/000110465923059126/0001104659-23-059126-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/744452/000110465923059126/tm2315498d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T05:15:11.501016+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c3f86fa0c3c1bea8ae1b8835a5ac5a09bc1ce46f","claim":"BNB PLUS CORP. reported second quarter of fiscal 2023 ended March 31, 2023 results: revenue $4.4 million.","evidence_excerpt":"Total revenues were $4.4 million for the three-month period ended March 31, 2023","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/744452/000110465923059126/0001104659-23-059126-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter of fiscal 2023 ended March 31, 2023"},{"label":"Revenue","value":"$4.4 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}